Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
Provided By GlobeNewswire
Last update: Feb 7, 2025
Following DSMB recommendation, the Company has voluntarily paused enrollment and dosing in the BEACON-IPF Phase 2b trial and will monitor current patients while data is reviewed
Read more at globenewswire.com3.08
+0.07 (+2.33%)
Find more stocks in the Stock Screener
PLRX Latest News and Analysis
10 days ago - ChartmillUnusual volume stocks in Wednesday's sessionDiscover the stocks with unexpected trading volume in today's session on the US markets.
12 days ago - ChartmillWhich stocks are experiencing notable movement on Monday?Keep an eye on the top gainers and losers in Monday's session, as they reflect the most notable price movements.
12 days ago - ChartmillLet's have a look at the top gainers and losers in the middle of the day of today's session.Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.
12 days ago - ChartmillThe market is filled with gapping stocks in Monday's session.Let's delve into the US markets on Monday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
12 days ago - ChartmillMonday's pre-market session: top gainers and losersDiscover the top movers in Monday's pre-market session and stay informed about market dynamics.
